Selonsertib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSelonsertib
Drug Alias Name司隆色替Selonsertibum瑟隆舍替NS3988A2TCGS-4997 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis signal-regulating kinase 1 inhibitors
TargetsApoptosis signal-regulating kinase 1
Therapy Area/IndicationsDiabetic NephropathiesPulmonary Arterial HypertensionHepatitis, Alcoholic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[28] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGilead Inc
China Registration ClassN/A

Develop Information

Active CompaniesGilead Sciences IncGilead Sciences Ireland UcRottendorf Pharma Gmbh +[4] 
Inactive CompaniesHepquant Llc
Active IndicationsDiabetic NephropathiesHepatitis, AlcoholicMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsPulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A